See also stories tagged with Drug discovery
A team of researchers has developed a microfluidic system to tackle antimicrobial resistance (AMR). Operating at the picoliter scale, the system condenses billions of bacterial cells into a confined microenvironment, accelerating ...
Organic semiconductors represent a transformative technology that bridges traditional electronics with the versatility of organic materials. They make flexible, wearable devices and next-generation displays possible.
New research in FEBS Open Bio reveals insights into the venom of two of the most venomous fish species on Earth: the estuarine stonefish (Synanceia horrida) and the reef stonefish (Synanceia verrucosa), which are typically ...
A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree ...
Plants, fungi and bacteria produce a variety of bioactives that alter cell metabolism, sometimes to the point of cell death. This makes them promising candidates for new anti-cancer drugs. Although a diverse range of bioactives ...
Researchers at the University of Liverpool have developed AI-driven mobile robots that can carry out chemical synthesis research with extraordinary efficiency.
Texas A&M AgriLife researchers uncovered a promising target for controlling gene expression and other cellular processes, which could lead to advancements in crop resilience and our understanding of certain human diseases.
New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new drugs. The next step is to ...
Unlike most cells in the human body, stem cells have the unique ability to divide indefinitely. This property makes them especially appealing to scientists exploring ways to extend human lifespans or develop new methods for ...
A innovative molecular "cut and sew" process by University of Dundee scientists has allowed the design of a research tool that will accelerate drug design for diseases for which no other options exist, including cancer.
